Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXALIPLATIN for Plasmablastic lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where OXALIPLATIN was used for Plasmablastic lymphoma.

Most Reported Side Effects for OXALIPLATIN

Side Effect Reports % Deaths Hosp.
Diarrhoea 4,963 8.8% 696 2,460
Nausea 4,250 7.5% 351 1,799
Neuropathy peripheral 3,662 6.5% 228 489
Off label use 3,603 6.4% 427 1,258
Neutropenia 3,391 6.0% 426 803
Vomiting 3,383 6.0% 377 1,760
Disease progression 3,370 6.0% 773 465
Thrombocytopenia 2,886 5.1% 367 903
Dyspnoea 2,779 4.9% 163 1,160
Pyrexia 2,269 4.0% 221 1,622
Fatigue 2,007 3.6% 207 732
Anaemia 1,898 3.4% 310 790
Asthenia 1,891 3.4% 246 844
Drug ineffective 1,768 3.1% 430 370
Decreased appetite 1,706 3.0% 219 801

Other Indications for OXALIPLATIN

Colon cancer (5,829) Colorectal cancer metastatic (4,638) Product used for unknown indication (4,407) Adenocarcinoma of colon (3,464) Colorectal cancer (2,951) Gastric cancer (2,711) Rectal cancer (2,402) Diffuse large b-cell lymphoma (2,070) Pancreatic carcinoma (1,941) Adenocarcinoma gastric (1,778)

Other Drugs Used for Plasmablastic lymphoma

CYCLOPHOSPHAMIDE (402) VINCRISTINE (377) DOXORUBICIN (354) ETOPOSIDE (344) PREDNISONE (258) BORTEZOMIB (216) METHOTREXATE (112) PREDNISOLONE (111) RITUXIMAB (94) DARATUMUMAB (79)

Related Pages

OXALIPLATIN Full Profile All Plasmablastic lymphoma Drugs OXALIPLATIN Demographics OXALIPLATIN Timeline